JP2004189733A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004189733A5 JP2004189733A5 JP2003393809A JP2003393809A JP2004189733A5 JP 2004189733 A5 JP2004189733 A5 JP 2004189733A5 JP 2003393809 A JP2003393809 A JP 2003393809A JP 2003393809 A JP2003393809 A JP 2003393809A JP 2004189733 A5 JP2004189733 A5 JP 2004189733A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- compound according
- formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 10
- 125000004432 carbon atom Chemical group C* 0.000 claims 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 8
- -1 methylpiperazinyl Chemical group 0.000 claims 7
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 239000001301 oxygen Substances 0.000 claims 4
- 125000004076 pyridyl group Chemical group 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011593 sulfur Substances 0.000 claims 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 3
- 230000003444 anaesthetic effect Effects 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- 235000019000 fluorine Nutrition 0.000 claims 3
- 125000001153 fluoro group Chemical group F* 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims 3
- 125000004434 sulfur atom Chemical group 0.000 claims 3
- 125000005871 1,3-benzodioxolyl group Chemical group 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 125000004122 cyclic group Chemical group 0.000 claims 2
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 2
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- 239000000932 sedative agent Substances 0.000 claims 2
- 230000001624 sedative effect Effects 0.000 claims 2
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- GWVMLCQWXVFZCN-UHFFFAOYSA-N isoindoline Chemical group C1=CC=C2CNCC2=C1 GWVMLCQWXVFZCN-UHFFFAOYSA-N 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 0 *N(C(c1c2cc3Nc3c1)I)C2=* Chemical compound *N(C(c1c2cc3Nc3c1)I)C2=* 0.000 description 20
- BTQZKHUEUDPRST-UHFFFAOYSA-N Cc1cccc(F)c1 Chemical compound Cc1cccc(F)c1 BTQZKHUEUDPRST-UHFFFAOYSA-N 0.000 description 4
- INTDQTYSKQLTRJ-UHFFFAOYSA-N CCCCN(CCC)C(C=C)=O Chemical compound CCCCN(CCC)C(C=C)=O INTDQTYSKQLTRJ-UHFFFAOYSA-N 0.000 description 2
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003393809A JP4205559B2 (ja) | 2002-11-26 | 2003-11-25 | イソインドリン誘導体 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002342399 | 2002-11-26 | ||
| JP2003393809A JP4205559B2 (ja) | 2002-11-26 | 2003-11-25 | イソインドリン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004189733A JP2004189733A (ja) | 2004-07-08 |
| JP2004189733A5 true JP2004189733A5 (enExample) | 2007-01-18 |
| JP4205559B2 JP4205559B2 (ja) | 2009-01-07 |
Family
ID=32774779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003393809A Expired - Fee Related JP4205559B2 (ja) | 2002-11-26 | 2003-11-25 | イソインドリン誘導体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4205559B2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1951707A1 (en) * | 2005-11-01 | 2008-08-06 | Janssen Pharmaceutica N.V. | Substituted pyrrolones as allosteric modulators of glucokinase |
| EP1951706A1 (en) * | 2005-11-01 | 2008-08-06 | Janssen Pharmaceutica N.V. | Dihydroisoindolones as allosteric modulators of glucokinase |
| US8796313B2 (en) * | 2005-11-01 | 2014-08-05 | Janssen Pharmaceutica N.V. | Substituted dihydroisoindolones as allosteric modulators of glucokinase |
| WO2007053765A2 (en) * | 2005-11-01 | 2007-05-10 | Janssen Pharmaceutica N.V. | Substituted cycloalkylpyrrolones as allosteric modulators of glucokinase |
| WO2014114779A1 (en) * | 2013-01-28 | 2014-07-31 | H. Lundbeck A/S | N-substituted-5-substituted phthalamic acids as sortilin inhibitors |
-
2003
- 2003-11-25 JP JP2003393809A patent/JP4205559B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2329263C2 (ru) | Производные имида индолилмалеиновой кислоты как ингибиторы протеинкиназы с | |
| CA2505029A1 (en) | Isoindoline derivatives | |
| JP2019534260A5 (enExample) | ||
| JP2004516293A5 (enExample) | ||
| JP2015533177A5 (enExample) | ||
| CA2682329A1 (en) | Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists | |
| JP2004513168A5 (enExample) | ||
| GB0315966D0 (en) | Compounds | |
| JP2007534702A5 (enExample) | ||
| CA2494613A1 (en) | Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors | |
| JP2012528166A5 (enExample) | ||
| JP2006500370A5 (enExample) | ||
| JP2012522056A5 (enExample) | ||
| JP2005511699A5 (enExample) | ||
| JP2010538076A5 (enExample) | ||
| JP2005523310A5 (enExample) | ||
| JP2005529956A5 (enExample) | ||
| JP2013542213A5 (enExample) | ||
| JP2005509622A5 (enExample) | ||
| AR050436A1 (es) | Inhibidores de azaindol de mtp y apob | |
| JP2006509015A5 (enExample) | ||
| MX2008000115A (es) | Derivados de piperidina utiles como antagonistas de histamina h3. | |
| ATE129241T1 (de) | Derivate von 1-naphthylpiperazin, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| JP2005536519A5 (enExample) | ||
| ATE450525T1 (de) | Kohlenstoffgebundene substituierte piperidine und derivate daraus als histamin-h3-antagonisten |